| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/16/2007 | US20070190147 Immediate release, divisible, layered pharmaceutical tablet that has two or more segments, a height that exceeds the width of the tablet, and at least two different active ingredients; calcium channel blocker (amlodipine), an angiotensin converting enzyme inhibitor (benazepril), diuretic (chlorthalidone) |
| 08/16/2007 | US20070190146 Pharmaceutical Multilayer Tablet for Controlled Release of Active Ingredients With Highly pH-Dependent Solubility |
| 08/16/2007 | US20070190145 Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids |
| 08/16/2007 | US20070190144 Multilayer tablet |
| 08/16/2007 | US20070190143 Disintegrating tablets comprising licarb azepine |
| 08/16/2007 | US20070190142 Dosage forms for the delivery of drugs of abuse and related methods |
| 08/16/2007 | US20070190141 Extended release opiate composition |
| 08/16/2007 | US20070190140 Pharmaceutical Composition in the Form of a Gastric-Resident Tablet Containing an Active Principle |
| 08/16/2007 | US20070190139 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/16/2007 | US20070190137 Osmotic dosage form with controlled release and fast release aspects |
| 08/16/2007 | US20070190136 Process for producing fenofibrate tablets |
| 08/16/2007 | US20070190135 Phosphate-binding polymer and tablets using the same |
| 08/16/2007 | US20070190134 Compositions containing nicorandil, preparation method and use |
| 08/16/2007 | US20070190133 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190131 Press-fit rapid release medicament and method and apparatus of manufacturing |
| 08/16/2007 | US20070190130 Protein hydrolysate excipients |
| 08/16/2007 | US20070190129 Sustained release dosage forms of ziprasidone |
| 08/16/2007 | US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors) |
| 08/16/2007 | US20070190127 Extended release of neuregulin for improved cardiac function |
| 08/16/2007 | US20070190126 Method for treating generalized and focal peripheral neuropathies |
| 08/16/2007 | US20070190123 Cover material and plaster with cover material |
| 08/16/2007 | US20070190121 Non-Absorbent Articles Containing Additives for Inhibiting the Production of TSST-1 |
| 08/16/2007 | US20070190119 Antimicrobial product and method for using the same |
| 08/16/2007 | US20070190118 Resin composition and utilizing the same, furniture, electrical household appliance and molding |
| 08/16/2007 | US20070190117 Buccal formulations of galanthamine and uses thereof |
| 08/16/2007 | US20070190114 Antioxidant health lozenges |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190111 Ocular therapeutic agent delivery devices and methods for making and using such devices |
| 08/16/2007 | US20070190102 Method of preparing hydroxyapatite based drug delivery implant for infection and cancer treatment |
| 08/16/2007 | US20070190093 Nonflammable propellant blend |
| 08/16/2007 | US20070190090 Sialagogue based oral care products |
| 08/16/2007 | US20070190085 Stable pharmaceutical compositions, processes for making the same and methods of their use |
| 08/16/2007 | US20070190084 Polymer Network Compositions And Associated Methods |
| 08/16/2007 | US20070190083 containing biocompatable wetting fluid, disruptable upon wetting to form conformable putty or paste; lyophilization collagenous material |
| 08/16/2007 | US20070190082 Perflurochemical Treatment Process And Apparatus |
| 08/16/2007 | US20070190081 Aqueous suspension for nasal drops |
| 08/16/2007 | US20070190080 Non-aqueous compositions for oral delivery of insoluble bioactive agents |
| 08/16/2007 | US20070190040 Recombinant p53 adenovirus methods and compositions |
| 08/16/2007 | US20070190026 Method Of Treatment Using Interferon-Tau |
| 08/16/2007 | US20070190020 composition in form of tablet comprising wet granulated salt of (poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)hydrochloride) and pharmaceutical excipient, wherein salt is granulated using a granulation liquid of an organic solvent or organic solvent/water mixture |
| 08/16/2007 | US20070190019 Compositions and methods for topical administration |
| 08/16/2007 | US20070190017 Porous cellulose aggregate and formed product composition comprising the same |
| 08/16/2007 | US20070189988 Cosmetic and dermatologic oxygen carrier system |
| 08/16/2007 | US20070189980 Compositions and methods for treating alopecia |
| 08/16/2007 | US20070189979 Particles |
| 08/16/2007 | US20070189978 Compositions and methods for dermally treating musculoskeletal pain |
| 08/16/2007 | US20070189977 Spray-on formulations and methods for dermal delivery of drugs |
| 08/16/2007 | US20070189976 Administering pharmaceutical compositions to the mammalian central nervous system |
| 08/16/2007 | US20070189975 Hydrophilic matrix for delivery of active agent and product containing same |
| 08/16/2007 | US20070189968 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 08/16/2007 | US20070189962 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2007 | US20070189114 Multi-chamber supercavitation reactor |
| 08/16/2007 | DE10234673B4 Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren Hot melt TTS for administering rotigotine and method for its production and use of rotigotine in the production of a TTS in a hot melt procedure |
| 08/16/2007 | DE102006053374A1 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz Pharmaceutical formulations for aerosols with two or more active ingredients and at least one surface-active substance |
| 08/16/2007 | DE102006006618A1 Herstellung mikroskaliger Polymer-,Wirkstoff-oder Polymer-Wirkstoff-Partikel durch Sprüh-Mahl-Trocknung einer Lösung in einer Mühle Micrometer-polymer, drug or polymer-drug particles by spray drying a solution grinding in a mill |
| 08/16/2007 | CA2642238A1 Palatable support with an improved formula |
| 08/16/2007 | CA2642082A1 Microtablet-based pharmaceutical preparation |
| 08/16/2007 | CA2641883A1 Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant |
| 08/16/2007 | CA2641854A1 Neutralization of bacterial spores |
| 08/16/2007 | CA2641852A1 Coated tablets, their methods of preparation, and related uses |
| 08/16/2007 | CA2641827A1 Nebulised antibiotics for inhalation therapy |
| 08/16/2007 | CA2641665A1 Modified release formulation |
| 08/16/2007 | CA2641638A1 A direct cellular energy delivery system |
| 08/16/2007 | CA2641588A1 Stabilized compositions of proteins having a free thiol moiety |
| 08/16/2007 | CA2641456A1 Compositions comprising a bisphosphonate and an antifolate |
| 08/16/2007 | CA2641450A1 Spill resistant antibiotic formulations |
| 08/16/2007 | CA2641432A1 Ultrasound activated medical device |
| 08/16/2007 | CA2641351A1 Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water |
| 08/16/2007 | CA2641263A1 Sialagogue based oral care products |
| 08/16/2007 | CA2641043A1 Polymeric implant and a process for obtaining a polymeric implant |
| 08/16/2007 | CA2640472A1 Dipyridamole extended-release formulations and process for preparing same |
| 08/16/2007 | CA2640094A1 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| 08/16/2007 | CA2640013A1 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| 08/16/2007 | CA2635841A1 Stable pharmaceutical formulations of montelukast sodium |
| 08/16/2007 | CA2635797A1 Stable formulations, and methods of their preparation and use |
| 08/15/2007 | EP1818409A1 Transfer of mRNAusing polycationic compounds |
| 08/15/2007 | EP1818362A1 Film and film-forming compositions |
| 08/15/2007 | EP1818064A2 Methods of treating skin to enhance therapeutic treatment thereof |
| 08/15/2007 | EP1818057A1 Stable pharmaceutical formulations of montelukast sodium |
| 08/15/2007 | EP1818051A1 Microgranules of morphine sulphate, preparation method and composition containing them |
| 08/15/2007 | EP1818050A1 Stable pharmaceutical compositions comprising a HMG-CoA reductase inhibitor |
| 08/15/2007 | EP1818049A2 Stabilized Atorvastatin |
| 08/15/2007 | EP1818048A1 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
| 08/15/2007 | EP1818047A2 Oral administration form for difficulty soluble basic active ingredients |
| 08/15/2007 | EP1818046A1 Drug delivery device |
| 08/15/2007 | EP1818045A1 Antiphlogistic and analgesic compound for topical use in an area of an animal locomotive system |
| 08/15/2007 | EP1818041A2 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid |
| 08/15/2007 | EP1818039A2 A local drug-release system and a method of the manufacture thereof |
| 08/15/2007 | EP1818029A2 Sequential drug delivery systems |
| 08/15/2007 | EP1817347A1 Method of cross-linking hyaluronic acid with divinylsulfone |
| 08/15/2007 | EP1817065A2 Viscoelastic solutions containing sodium hyaluronate and hydroxypropylmethyl- cellulose, preparation and uses |
| 08/15/2007 | EP1817051A2 Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose |
| 08/15/2007 | EP1817043A1 Encapsulated bacteriophage formulation |
| 08/15/2007 | EP1817035A1 Solid formulations of liquid biologically active agents |
| 08/15/2007 | EP1817021A1 Nsaid compositions exhibiting clinical superiority |
| 08/15/2007 | EP1817015A2 Pharmaceutical formulations |
| 08/15/2007 | EP1817014A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 08/15/2007 | EP1817013A1 Enteric coated bead comprising ixabepilone, and preparation thereof |
| 08/15/2007 | EP1817012A2 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |